Alkermes (ALKS) Finished Goods (2011 - 2026)
Alkermes (ALKS) reported Finished Goods of $144.9 million for Q1 2026, up 266.38% year-over-year from $39.5 million in Q1 2025, and up 283.92% quarter-over-quarter from $37.7 million in Q4 2025.
Alkermes (ALKS) Finished Goods (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Finished Goods data on file, last reported at $144.9 million in Q1 2026.
- Finished Goods for Q1 2026 came in at $144.9 million, up 266.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $144.9 million (up 266.38% YoY), and the FY2025 annual result was $37.7 million, up 22.23% from the prior year.
- Finished Goods climbed to $144.9 million in Q1 2026 per ALKS's latest filing, from $37.7 million in the prior quarter.
- Over five years, Finished Goods peaked at $144.9 million in Q1 2026 and troughed at $28.6 million in Q3 2022.
- A 5-year average of $47.6 million and a median of $42.1 million in 2025 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2024 and 2026: Finished Goods tumbled 33.09% in 2024, then surged 266.38% in 2026.
- A 5-year view of Finished Goods shows it stood at $44.1 million in 2022, then grew by 4.58% to $46.1 million in 2023, then sank by 33.09% to $30.9 million in 2024, then gained by 22.23% to $37.7 million in 2025, then surged by 283.92% to $144.9 million in 2026.
- Business Quant data shows ALKS's Finished Goods at $144.9 million in Q1 2026, $37.7 million in Q4 2025, and $35.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.89 Mn |
| Dec 31, 2025 | 37.74 Mn |
| Sep 30, 2025 | 35.36 Mn |
| Jun 30, 2025 | 42.11 Mn |
| Mar 31, 2025 | 39.55 Mn |
| Dec 31, 2024 | 30.88 Mn |
| Sep 30, 2024 | 35.74 Mn |
| Jun 30, 2024 | 49.52 Mn |
| Mar 31, 2024 | 49.29 Mn |
| Dec 31, 2023 | 46.15 Mn |
| Sep 30, 2023 | 50.41 Mn |
| Jun 30, 2023 | 52.57 Mn |
| Mar 31, 2023 | 51.28 Mn |
| Dec 31, 2022 | 44.13 Mn |
| Sep 30, 2022 | 28.59 Mn |
| Jun 30, 2022 | 32.30 Mn |
| Mar 31, 2022 | 38.97 Mn |
| Dec 31, 2021 | 35.11 Mn |
| Sep 30, 2021 | 41.55 Mn |
| Jun 30, 2021 | 34.03 Mn |